These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31187480)

  • 41. Histopathological comparison of lesional and perilesional skin in melasma: A cross-sectional analysis.
    Gautam M; Patil S; Nadkarni N; Sandhu M; Godse K; Setia M
    Indian J Dermatol Venereol Leprol; 2019; 85(4):367-373. PubMed ID: 30516167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study.
    Sarkar R; Kaur C; Bhalla M; Kanwar AJ
    Dermatol Surg; 2002 Sep; 28(9):828-32; discussion 832. PubMed ID: 12269877
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The dermoscopic characteristics of melasma in relation to different skin phototypes, distribution patterns and wood lamp findings: a cross-sectional study of 236 melasma lesions.
    Bostan E; Cakir A
    Arch Dermatol Res; 2023 Sep; 315(7):1927-1938. PubMed ID: 36853510
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Melasma: treatment strategy.
    Sehgal VN; Verma P; Srivastava G; Aggarwal AK; Verma S
    J Cosmet Laser Ther; 2011 Dec; 13(6):265-79. PubMed ID: 21981383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
    Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
    J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of therapeutic effects of conventional and liposomal form of 4% topical hydroquinone in patients with melasma.
    Taghavi F; Banihashemi M; Zabolinejad N; Salehi M; Jaafari MR; Marhamati H; Golnouri F; Dorri M
    J Cosmet Dermatol; 2019 Jun; 18(3):870-873. PubMed ID: 30105847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Usefulness of retinoic acid in the treatment of melasma.
    Pathak MA; Fitzpatrick TB; Kraus EW
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):894-9. PubMed ID: 3534025
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Melasma and assessment of the quality of life in Brazilian women.
    Ikino JK; Nunes DH; Silva VP; Fröde TS; Sens MM
    An Bras Dermatol; 2015; 90(2):196-200. PubMed ID: 25830989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of Intense Pulse Light Therapy and Tripple Combination Cream Versus Intense Pulse Light Therapy and Tripple Combination Cream Alone in Epidermal Melasma Treatment.
    Shakeeb N; Noor SM; Ullah G; Paracha MM
    J Coll Physicians Surg Pak; 2018 Jan; 28(1):13-16. PubMed ID: 29290184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Body dysmorphic disorder symptoms in patients with melasma.
    Zhu Y; Du X; Shen S; Song X; Xiang W
    Int J Dermatol; 2024 Jun; 63(6):787-794. PubMed ID: 38251731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk factors for facial melasma in women: a case-control study.
    Handel AC; Lima PB; Tonolli VM; Miot LD; Miot HA
    Br J Dermatol; 2014 Sep; 171(3):588-94. PubMed ID: 24749693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and validation of a Hindi language health-related quality of life questionnaire for melasma in Indian patients.
    Sarkar R; Garg S; Dominguez A; Balkrishnan R; Jain RK; Pandya AG
    Indian J Dermatol Venereol Leprol; 2016; 82(1):16-22. PubMed ID: 26728805
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of testosterone level with melasma in men: a case-control study in Indonesia.
    Nukana RP; Rusyati LMM; Praharsini GAA; Winaya KK; Suryawati N; Karna NLPRV
    Pan Afr Med J; 2022; 43():194. PubMed ID: 36942149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinicoaetiological, hormonal and histopathological characteristics of melasma in men.
    Handa S; De D; Khullar G; Radotra BD; Sachdeva N
    Clin Exp Dermatol; 2018 Jan; 43(1):36-41. PubMed ID: 28940653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers.
    Kauvar AN
    Lasers Surg Med; 2012 Feb; 44(2):117-24. PubMed ID: 22334295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment and Comparison of Quality of Life in Patients with Melasma and Vitiligo.
    Amatya B; Pokhrel DB
    Kathmandu Univ Med J (KUMJ); 2019; 17(66):114-118. PubMed ID: 32632057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and efficacy of glycolic acid facial peel in Indian women with melasma.
    Javaheri SM; Handa S; Kaur I; Kumar B
    Int J Dermatol; 2001 May; 40(5):354-7. PubMed ID: 11555002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The efficacy of a broad-spectrum sunscreen in the treatment of melasma.
    Vázquez M; Sánchez JL
    Cutis; 1983 Jul; 32(1):92, 95-6. PubMed ID: 6349944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Melasma pathogenesis: a review of the latest research, pathological findings, and investigational therapies.
    Rajanala S; Maymone MBC; Vashi NA
    Dermatol Online J; 2019 Oct; 25(10):. PubMed ID: 31735001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Topical 10% zinc sulfate solution for treatment of melasma.
    Sharquie KE; Al-Mashhadani SA; Salman HA
    Dermatol Surg; 2008 Oct; 34(10):1346-9. PubMed ID: 18616534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.